These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 3070468)
1. Morphometric observations on some aspects of Barrett's esophagus. Fichera G; Macaluso G Pathologica; 1988; 80(1067):333-41. PubMed ID: 3070468 [No Abstract] [Full Text] [Related]
2. [Barrett's esophagus and primary adenocarcinoma of the esophagus]. Seco JL; Velasco A; Hilario E; Corrales JI; Alvarez JL; Ojeda C; Santamaría JL Rev Esp Enferm Apar Dig; 1981 May; 59(5):617-26. PubMed ID: 7291673 [No Abstract] [Full Text] [Related]
3. Adenocarcinoma in situ in Barrett's esophagus with stricture of 10-yr duration: a cytological diagnosis. Bauer W; Ali SZ; Urmacher C; Katz S Am J Gastroenterol; 1996 Aug; 91(8):1650-1. PubMed ID: 8759681 [No Abstract] [Full Text] [Related]
4. Adenocarcinoma arising in Barrett's esophagus after total gastrectomy. Tada T; Suzuki T; Iwafuchi M; Watanabe H; Katayanagi N; Aizawa K; Nishimaki T; Tanaka O; Muto T Am J Gastroenterol; 1990 Nov; 85(11):1503-6. PubMed ID: 2239878 [TBL] [Abstract][Full Text] [Related]
5. Persistent dysplasia within long-segment Barrett's esophagus in a patient with Gardner's syndrome. Vieth M; Stolte M Endoscopy; 2005 Dec; 37(12):1254; author reply 1255. PubMed ID: 16329029 [No Abstract] [Full Text] [Related]
6. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. May A; Gossner L; Pech O; Müller H; Vieth M; Stolte M; Ell C Endoscopy; 2002 Aug; 34(8):604-10. PubMed ID: 12173079 [TBL] [Abstract][Full Text] [Related]
7. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins. Chatelain D; Fléjou JF Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310 [TBL] [Abstract][Full Text] [Related]
8. Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997. Morgan G Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):265. PubMed ID: 9521445 [No Abstract] [Full Text] [Related]
10. [Expression and clinical significance of the AgNOR and PCNA in Barrett's adenocarcinoma and its precancerous lesions]. Li H; Yao S; Stuart R Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):286-8. PubMed ID: 7587897 [TBL] [Abstract][Full Text] [Related]
11. Barrett's esophagus-is it bad for your health? Falk GW Am J Gastroenterol; 2005 Dec; 100(12):2622-3. PubMed ID: 16393210 [TBL] [Abstract][Full Text] [Related]
18. Neoplastic risk assessment in Barrett's esophagus: How far have we come? Noffsinger A Hum Pathol; 2003 Oct; 34(10):965-7. PubMed ID: 14608528 [No Abstract] [Full Text] [Related]
20. Barrett's: do we still need goblet cells for diagnosis? Lenglinger J; Riegler M Am J Gastroenterol; 2009 Sep; 104(9):2355-6; author reply 2356-7. PubMed ID: 19727095 [No Abstract] [Full Text] [Related] [Next] [New Search]